Skip to main content
Erschienen in: Supportive Care in Cancer 10/2018

05.05.2018 | Original Article

Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center

verfasst von: Mitra Tewes, Teresa Rettler, Nathalie Wolf, Jörg Hense, Martin Schuler, Martin Teufel, Mingo Beckmann

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Early integration of palliative care (PC) is recommended. The determination of predictors for patients’ request for PC may guide implementation in clinical practice. Toward this end, we analyzed the symptom burden and distress of cancer patients in outpatient care and examined their need and request for PC.

Methods

Between October 2013 and March 2016, 705 patients receiving outpatient cancer treatment took part in the survey. We used the new MInimal DOcumentation System to detect symptom clusters. Additionally, patients’ request for palliative and psychosocial support was assessed. Groups of patients with PC request were compared to patients without PC request regarding their symptom clusters. Logistic regression analysis was applied to discover significant predictors for the requested inclusion of PC.

Results

A total of 159 patients (25.5%) requested additional support by PC. Moderate and severe tiredness (40.3%), weakness (37.9%), pain (25.0%), loss of appetite (22.3%), and dyspnea (19.1%) were the most frequent symptoms. The group of patients requesting PC differed significantly in terms of pain, nausea, dyspnea, constipation, weakness, loss of appetite, tiredness, depression, and anxiety from patients without request for PC (p < .01). The perceived need for PC was identified by the significant predictors “depression,” “anxiety,” and “weakness” with an explained variance of 22%.

Conclusion

Combining a standardized screening questionnaire and the assessment of patients’ request for PC allows systematic monitoring for patients’ need for PC in a large Medical Oncology clinic. Depression, anxiety, and weakness are predictors of requesting PC service by patients receiving outpatient cancer treatment.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Munkres A, Oberst MT, Hughes SH (1992) Appraisal of illness, symptom distress, self-care burden, and mood states in patients receiving chemotherapy for initial and recurrent cancer. Oncol Nurs Forum 19(8):1201–1209PubMed Munkres A, Oberst MT, Hughes SH (1992) Appraisal of illness, symptom distress, self-care burden, and mood states in patients receiving chemotherapy for initial and recurrent cancer. Oncol Nurs Forum 19(8):1201–1209PubMed
2.
Zurück zum Zitat Whitmer KM, Pruemer JM, Nahleh ZA, Jazieh AR (2006) Symptom management needs of oncology outpatients. J Palliat Med 9(3):628–630CrossRefPubMed Whitmer KM, Pruemer JM, Nahleh ZA, Jazieh AR (2006) Symptom management needs of oncology outpatients. J Palliat Med 9(3):628–630CrossRefPubMed
3.
Zurück zum Zitat Rugno FC, Ribeiro Paiva BS, Paiva CE (2014) Early integration of palliative care facilitates the discontinuation of anticancer treatment in women with advanced breast or gynecologic cancers. Gynecol Oncol 135:249–254CrossRefPubMed Rugno FC, Ribeiro Paiva BS, Paiva CE (2014) Early integration of palliative care facilitates the discontinuation of anticancer treatment in women with advanced breast or gynecologic cancers. Gynecol Oncol 135:249–254CrossRefPubMed
5.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small lung cancer. N Engl J Med 363:733–742CrossRefPubMed Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small lung cancer. N Engl J Med 363:733–742CrossRefPubMed
7.
Zurück zum Zitat Fadul N, Elsayem A, Palmer JL, Del Fabbro E, Swint K, Li Z, Poulter V, Bruera E (2009) Supportive versus palliative care: what's in a name. Cancer 115:2013–2021CrossRefPubMed Fadul N, Elsayem A, Palmer JL, Del Fabbro E, Swint K, Li Z, Poulter V, Bruera E (2009) Supportive versus palliative care: what's in a name. Cancer 115:2013–2021CrossRefPubMed
8.
Zurück zum Zitat Lesnock JL, Arnold RM, Meyn LA, Buss MK, Quimper M, Krivak TC, Edwards RP, Chang JC (2013) Palliative care education in gynecologic oncology: a survey of the fellows. Gynecol Oncol 130:431–435CrossRefPubMed Lesnock JL, Arnold RM, Meyn LA, Buss MK, Quimper M, Krivak TC, Edwards RP, Chang JC (2013) Palliative care education in gynecologic oncology: a survey of the fellows. Gynecol Oncol 130:431–435CrossRefPubMed
9.
Zurück zum Zitat Bakitas M, Doyle Lyons K, Hegel MT, Ahles T (2013) Oncologists’ perspectives on concurrent palliative care in an NCI-designated Comprehensive Cancer Center. Palliat Support Care 11(5):415–423CrossRefPubMed Bakitas M, Doyle Lyons K, Hegel MT, Ahles T (2013) Oncologists’ perspectives on concurrent palliative care in an NCI-designated Comprehensive Cancer Center. Palliat Support Care 11(5):415–423CrossRefPubMed
11.
Zurück zum Zitat Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15(12):1407–1412 Riechelmann RP, Krzyzanowska MK, O'Carroll A, Zimmermann C (2007) Symptom and medication profiles among cancer patients attending a palliative care clinic. Support Care Cancer 15(12):1407–1412
12.
13.
Zurück zum Zitat Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Elsner F, Hormann E (2000) MIDOS-validation of a minimal documentation system for palliative medicine. Schmerz 14(4):231–239CrossRefPubMed Radbruch L, Sabatowski R, Loick G, Jonen-Thielemann I, Elsner F, Hormann E (2000) MIDOS-validation of a minimal documentation system for palliative medicine. Schmerz 14(4):231–239CrossRefPubMed
14.
Zurück zum Zitat Stiel S, Matthes ME, Bertram L, Ostgathe C, Elsner F, Radbruch L (2010) Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care: the German version of the Edmonton Symptom Assessment Scale (ESAS). Schmerz 24(6):596–604CrossRefPubMed Stiel S, Matthes ME, Bertram L, Ostgathe C, Elsner F, Radbruch L (2010) Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care: the German version of the Edmonton Symptom Assessment Scale (ESAS). Schmerz 24(6):596–604CrossRefPubMed
15.
Zurück zum Zitat Cohen J (1988) Statistical power analysis for the behavioral sciences. L. Erlbaum Associates, Hillsdale Cohen J (1988) Statistical power analysis for the behavioral sciences. L. Erlbaum Associates, Hillsdale
16.
Zurück zum Zitat Gaertner J, Wuerstlein R, Ostgathe C, Mallmann P, Harbeck N, Voltz R (2011) Facilitating early integration of palliative care into breast Cancer therapy. Promoting disease-specific guidelines. Breast Care 6:240–244CrossRefPubMedPubMedCentral Gaertner J, Wuerstlein R, Ostgathe C, Mallmann P, Harbeck N, Voltz R (2011) Facilitating early integration of palliative care into breast Cancer therapy. Promoting disease-specific guidelines. Breast Care 6:240–244CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hui D, Bruera E (2016) Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13:159–171CrossRefPubMed Hui D, Bruera E (2016) Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13:159–171CrossRefPubMed
20.
Zurück zum Zitat Morita T, Fujimoto K, Namba M, Sasaki N, Ito T, Yamada C, Ohba A, Hiroyoshi M, Niwa H, Yamada T, Noda (2008) Palliative care needs of cancer outpatients receiving chemotherapy: an audit of a clinical screening project. Support Care Cancer 16(1):101–107CrossRefPubMed Morita T, Fujimoto K, Namba M, Sasaki N, Ito T, Yamada C, Ohba A, Hiroyoshi M, Niwa H, Yamada T, Noda (2008) Palliative care needs of cancer outpatients receiving chemotherapy: an audit of a clinical screening project. Support Care Cancer 16(1):101–107CrossRefPubMed
22.
Zurück zum Zitat Levy M, Smith T, Alvarez-Perez A, Back A, Baker JN, Beck AC, Block S, Dalal S, Dans M, Fitch TR, Kapo J, Kutner JS, Kvale E, Misra S, Mitchell W, Portman DG, Sauer TM, Spiegel D, Sutton L, Szmuilowicz E, Taylor RM, Temel J, Tickoo R, Urba SG, Weinstein E (2016) Palliative Care Version 1.2016. J Natl Compr Cancer Netw 14(1):82–113CrossRef Levy M, Smith T, Alvarez-Perez A, Back A, Baker JN, Beck AC, Block S, Dalal S, Dans M, Fitch TR, Kapo J, Kutner JS, Kvale E, Misra S, Mitchell W, Portman DG, Sauer TM, Spiegel D, Sutton L, Szmuilowicz E, Taylor RM, Temel J, Tickoo R, Urba SG, Weinstein E (2016) Palliative Care Version 1.2016. J Natl Compr Cancer Netw 14(1):82–113CrossRef
Metadaten
Titel
Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center
verfasst von
Mitra Tewes
Teresa Rettler
Nathalie Wolf
Jörg Hense
Martin Schuler
Martin Teufel
Mingo Beckmann
Publikationsdatum
05.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2018
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4245-7

Weitere Artikel der Ausgabe 10/2018

Supportive Care in Cancer 10/2018 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.